SHIFT Newsroom · GLOBAL
Trial record: blood levels after two cagrilintide formulations
Registry status checked on 3 October 2026: completed.
ClinicalTrials.gov lists NCT07605052, concerning blood levels after two cagrilintide formulations, as completed. The record was first posted on 2026-05-22 and last updated on 2026-09-04; SHIFT checked it on 3 October 2026. The recorded study-completion date is 2026-08-19.
This phase 1 study compares drug concentrations in blood after different formulations. It is not a trial establishing a weight-loss advantage.
No results tables were posted in this registry record when checked. That does not establish that no results have been published elsewhere. A registry entry is not a UK marketing authorisation or confirmation of NHS access.
SHIFT’s take
Keep the trial status, published results and UK treatment access separate. Do not change treatment on the basis of a registration.